Flavonoid Intake and Bone Health

Department of Nutrition Science, Purdue University, West Lafayette, Indiana 47907-2059, USA.
Journal of Nutrition in Gerontology and Geriatrics 07/2012; 31(3):239-53. DOI: 10.1080/21551197.2012.698220
Source: PubMed


Flavonoids, found in a wide diversity of plant foods from fruits and vegetables, herbs and spices, essential oils, and beverages, have the most potential of dietary components for promotion of bone health beyond calcium and vitamin D. Recent epidemiological studies show flavonoid consumption to have a stronger association with bone than general fruit and vegetable consumption. Bioactive flavonoids are being assessed for properties beyond their chemical antioxidant capacity, including anti-inflammatory actions. Some have been reported to enhance bone formation and to inhibit bone resorption through their action on cell signaling pathways that influence osteoblast and osteoclast differentiation. Future research is needed to determine which of the flavonoids and their metabolites are most effective and at what dose, as well as the mechanism of modulating cellular events, in order to set priorities for clinical trials.

1 Follower
31 Reads
  • Source
    • "Flavonoids represent a diverse range of polyphenolic compounds that occur naturally in plant foods. Extensive studies have shown that dietary flavonoids consumption is inversely associated with the incidence of bone disorders (Hardcastle et al., 2011; Peng et al., 2013; Wang et al., 2012; Weaver et al., 2012). On the cellular level, enormous studies have been done investigating the effects of flavonoids on osteoblasts and osteoclasts. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Bone homeostasis is maintained by the balance between osteoblastic bone formation and osteoclastic bone resorption. Osteoclasts are multinucleated cells derived from hematopoietic stem cells (HSCs) or monocyte/macrophage progenitor cells and formed by osteoclasts precursors (OCPs) fusion. Cyanidin is an anthocyanin widely distributed in food diet with novel antioxidant activity. However, the effect of cyanidin on osteoclasts is still unknown. We investigated the effect of cyanidin on RANKL-induced osteoclasts differentiation and cell fusion. The results showed that cyanidin had a dual effect on RANKL-induced osteoclastogenesis. Lower dosage of cyanidin (< 1μg/ml) has a promoting effect on osteoclastogenesis while higher dosage of cyanidin (> 10μg/ml) has an inhibitory effect. Fusogenic genes like CD9, ATP6v0d2, DC-STAMP, OC-STAMP and osteoclasts related genes like NFATc1, mitf and c-fos were all regulated by cyanidin consistent to its dual effect. Further exploration showed that low concentration of cyanidin could increase osteoclasts fusion whereas higher dosage of cyanidin lead to the increase of LXR-β expression and activation which is suppressive to osteoclasts differentiaton. All these results showed that cyanidin exhibits therapeutic potential in prevention of osteoclasts related bone disorders. This article is protected by copyright. All rights reserved
    Journal of Cellular Physiology 12/2014; DOI:10.1002/jcp.24916 · 3.84 Impact Factor
  • Source
    • "Flavonoids, which are naturally occurring polyphenolic compounds that form part of the human diet, have been reported to affect bone metabolism [13]. Among flavonoids, hesperetin (3′,5,7-trihydroxy-4-methoxyflavanone), which is a member of the flavanone subclass of flavonoids, is found mainly in citrus fruit. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hesperetin (3',5,7-trihydroxy-4-methoxyflavanone) is a metabolite of hesperidin (hesperetin-7-O-rutinoside), which belongs to the flavanone subgroup and is found mainly in citrus fruits. Hesperetin has been reported to be an effective osteoinductive compound in various in vivo and in vitro models. However, how hesperetin effects osteogenic differentiation is not fully understood. In this study, we investigated the capacity of hesperetin to stimulate the osteogenic differentiation of periodontal ligament stem cells (PDLSCs) and to relieve the anti-osteogenic effect of high glucose. Osteogenesis of PDLSCs was assessed by measurement of alkaline phosphatase (ALP) activity, and evaluation of the mRNA expression of ALP, runt-related gene 2 (Runx2), osterix (OSX), and FRA1 as osteogenic transcription factors, as well as assessment of protein expression of osteopontin (OPN) and collagen type IA (COLIA). When PDLSCs were exposed to a high concentration (30 mM) of glucose, osteogenic activity decreased compared to control cells. Hesperetin significantly increased ALP activity at doses of 1, 10, and 100 µM. Pretreatment of cells with hesperetin alleviated the high-glucose-induced suppression of the osteogenic activity of PDLSCs. Hesperetin scavenged intracellular reactive oxygen species (ROS) produced under high glucose condition. Furthermore, hesperetin increased the activity of the PI3K/Akt and β-catenin pathways. Consistent with this, blockage of Akt or β-catenin diminished the protective effect of hesperetin against high glucose-inhibited osteogenic differentiation. Collectively, our results suggest that hesperetin alleviates the high glucose-mediated suppression of osteogenic differentiation in PDLSCs by regulating ROS levels and the PI3K/Akt and β-catenin signaling pathways.
    PLoS ONE 06/2013; 8(6):e67504. DOI:10.1371/journal.pone.0067504 · 3.23 Impact Factor
  • Journal of Nutrition in Gerontology and Geriatrics 07/2012; 31(3):173-5. DOI:10.1080/21551197.2012.698210
Show more